Our teams of highly skilled, passionate people work across a broad range of research traditions that span the full spectrum of care – all the way from the lab to impacted individuals and communities. This unique approach allows us to attack infectious disease from every angle and maximises our chances of success.
For ongoing strategic growth and development of the Kirby Institute, we have identified and recognised four broad areas of research strength within which our Research Programs are grouped. Each Theme is led by a Theme Director, who provides high level executive oversight on matters of strategic and operational significance.
Basic Science and Pathogenesis
Understand infectious diseases and their behaviour at the cellular and molecular level in order to develop tests, vaccines and treatments.
- Immunovirology and Pathogenesis Program
- Infection Analytics Program
- Viral Immunology Systems Program
Theme Director: Professor Miles Davenport
Clinical Trials and Therapeutic Interventions
Develop and assess therapeutic interventions for maximum individual and community impact.
- Biostatistics and Databases Program
- Therapeutic and Vaccine Research Program
- Viral Hepatitis Clinical Research Program
Theme Director: Scientia Professor Gregory Dore
Populations and Prevention
Working with populations that are most impacted by infection, we study community knowledge, behaviours and barriers to inform effective and accessible solutions.
- Aboriginal and Torres Strait Islander Health Program
- HIV Epidemiology and Prevention Program
- Sexual Health Program
- Viral Hepatitis Epidemiology and Prevention Program
Theme Director: Professor Andrew Grulich
Design evidence-based programs that are implemented in a way that maximises successful health outcomes for all.
- Biosecurity Program
- Public Health Interventions Research Program
- Surveillance, Evaluation and Research Program
Theme Director: Professor Rebecca Guy
The Cross-cutting Initiatives act as review and advisory bodies for key operational and critical strategic research growth areas for the Kirby Institute. They include areas and initiatives that span the breadth of the Kirby Institute’s program and are led by senior researchers.
Aboriginal and Torres Strait Islander health, research and education
The Kirby Institute has established a Cross-Cutting Initiative in Aboriginal and Torres Strait Islander Health, Research and Education to advise on the development, interpretation, implementation, and presentation of an enhanced strategic commitment regarding Aboriginal and Torres Strait Islander-led work within the Institute.
The Advisory Committee supports Cross-Cutting Initiative, providing an opportunity for members to have input into projects through an exchange of ideas. also acting as a mechanism to support project outcomes effectively and appropriately with key stakeholders.
The Committee feeds back to the Kirby Institute’s Strategic Advisory Group and Executive Committee.
Cross-cutting Initiative Lead: Mr Robert Monaghan
Clinical Trial Research
The goals of the Clinical Research Cross Cutting Initiative are to align processes across the Institute that relate to the conduct of conducting ethical and best practice research across our populations of interest. Specifically, the Clinical Research CCI aims to streamline and optimize engagement both across the diversity of Kirby Institute programs, and with key UNSW stakeholders that are essential to the conduct of best clinical research practice including Legal, Insurance, and Research Ethics and Strategy Teams.
Health Economics and Health Systems
The overriding goal of this cross-cutting initiative is to enhance health system performance, improve health outcomes, and achieve greater value for public health resources. Our health economists and modellers work with clinicians, sociologists, statisticians, policy makers, health care managers and affected communities to improve how health care is delivered and financed in Australia and the Asia-Pacific region. We are recognised for our expertise in: health care financing; impact evaluation; economic evaluation; health technology assessment; process evaluation; priority setting; equity analysis; and modelling. We actively support research translation through for example, submissions for public funding to the Medical Services Advisory and bespoke short courses and mentoring to funders and policy makers. The Kirby Institute also houses the Health Economics Research Network (HERN), a UNSW-wide collaboration involving around 30 staff and students working and studying in the field. Our team are active members of the Australian Health Economics Society and Health Systems Global. In 2019, Virginia was voted by her peers onto the board of the International Health Economics Society.
Cross-cutting Initiative Lead: Professor Virginia Wiseman